BIM.PA

bioMérieux S.A. [BIM.PA] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

BIM.PA Stock Summary

The Moving Average Convergence Divergence (MACD) for BIM.PA recently turned positive (within last 10 days).

Top 10 Correlated Stocks

BIM.PA

In the News

BIM.PA Financial details

Company Rating

Market Cap

12.36B

Income

809.9M

Revenue

7.26B

Book val./share

Cash/share

Dividend

0.85

Dividend %

0.84%

Employees

13.41K

Optionable

Shortable

Yes

Earnings

14 Mar 2024

P/E

54.45

Forward P/E

PEG

6.92

P/S

6.48

P/B

3.31

P/C

P/FCF

123.38

Quick Ratio

0.43

Current Ratio

2.2

Debt / Equity

LT Debt / Equity

EPS (TTM)

6.86

EPS next Y

EPS next Q

EPS this Y

-21.09%

EPS next Y

EPS next 5Y

EPS last 5Y

5.58%

Revenue last 5Y

6.56%

Revenue Q/Q

7.6%

EPS Q/Q

21.17%

SMA20

-0.75%

SMA50

1.04%

SMA100

17.56%

Inst Own

Inst Trans

ROA

ROE

ROC

0.07%

Gross Margin

56%

Oper. Margin

17%

Profit Margin

12%

Payout

23%

Shs Outstand

Shs Float

Target Price

52W Range

84.54-108.9

52W High

+9.91%

52W Low

+41.31%

RSI

57.91

Rel Volume

1.23

Avg Volume

95.7K

Volume

117.52K

Perf Week

4.4%

Perf Month

3.31%

Perf Quarter

18.11%

Perf Half Y

11.46%

Beta

0.143

Volatility

1.8%, 2.31%

Prev Close

2.06%

Price

118.7

Change

2.33%

BIM.PA Financial Performance

BIM.PA Dividend History

BIM.PA Frequently Asked Questions

What is bioMérieux S.A. stock symbol ?

bioMérieux S.A. is a FR stock and trading under the symbol BIM.PA

What is bioMérieux S.A. stock quote today ?

bioMérieux S.A. stock price is $118.7 today.

Is bioMérieux S.A. stock public?

Yes, bioMérieux S.A. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 95.7K
Market Capitalization 12.36B
Employee 13.41K
CEO Mr. Pierre Boulud
Headquarters Marcy l'Étoile,FR
IPO Date 2004-07-07
Website https://www.biomerieux.com

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.